Identification of regulators of poly-ADP-ribose polymerase inhibitor response through complementary CRISPR knockout and activation screens

Inhibitors of poly-ADP-ribose polymerase 1 (PARPi) are highly effective in killing cells deficient in homologous recombination (HR); thus, PARPi have been clinically utilized to successfully treat BRCA2-mutant tumors. However, positive response to PARPi is not universal, even among patients with HR-...

Descripción completa

Detalles Bibliográficos
Autores principales: Clements, Kristen E., Schleicher, Emily M., Thakar, Tanay, Hale, Anastasia, Dhoonmoon, Ashna, Tolman, Nathanial J., Sharma, Anchal, Liang, Xinwen, Imamura Kawasawa, Yuka, Nicolae, Claudia M., Wang, Hong-Gang, De, Subhajyoti, Moldovan, George-Lucian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704667/
https://www.ncbi.nlm.nih.gov/pubmed/33257658
http://dx.doi.org/10.1038/s41467-020-19961-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704667/
https://www.ncbi.nlm.nih.gov/pubmed/33257658
http://dx.doi.org/10.1038/s41467-020-19961-w

Ejemplares similares